Cerebrospinal fluid concentrations of nitrate plus nitrite during the treatment of acute lymphoblastic leukaemia in childhood. 1998

R Surtees, and J Clelland, and S Heales
Institute of Child Health, University College London Medical School, UK.

To investigate the hypothesis that acute lymphoblastic leukaemia (ALL) and its treatment disturb central nervous system nitric oxide metabolism, 11 patients were studied. Serial cerebrospinal fluid (CSF) samples were collected throughout treatment and the concentration of nitrate plus nitrite (NOx) was measured. Compared to an age-matched reference population, CSF NOx was significantly increased before treatment and rose further during the induction phase of treatment. Concentrations remained high during consolidation treatment, but fell during continuing treatment and normalised by the end of treatment. In conclusion, ALL and its treatment cause an increase in central nervous system nitric oxide production. reserved.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D009566 Nitrates Inorganic or organic salts and esters of nitric acid. These compounds contain the NO3- radical. Nitrate
D009573 Nitrites Salts of nitrous acid or compounds containing the group NO2-. The inorganic nitrites of the type MNO2 (where M Nitrite
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000964 Antimetabolites, Antineoplastic Antimetabolites that are useful in cancer chemotherapy. Antineoplastic Antimetabolites
D054198 Precursor Cell Lymphoblastic Leukemia-Lymphoma A neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the most common cancer in children and accounts for the vast majority of all childhood leukemias. Leukemia, Lymphoblastic,Leukemia, Lymphoid, Acute,Lymphoblastic Leukemia,Lymphoblastic Lymphoma,Lymphocytic Leukemia, Acute,Lymphoma, Lymphoblastic,ALL, Childhood,Acute Lymphoid Leukemia,Leukemia, Acute Lymphoblastic,Leukemia, Lymphoblastic, Acute,Leukemia, Lymphoblastic, Acute, L1,Leukemia, Lymphoblastic, Acute, L2,Leukemia, Lymphoblastic, Acute, Philadelphia-Positive,Leukemia, Lymphocytic, Acute,Leukemia, Lymphocytic, Acute, L1,Leukemia, Lymphocytic, Acute, L2,Lymphoblastic Leukemia, Acute,Lymphoblastic Leukemia, Acute, Adult,Lymphoblastic Leukemia, Acute, Childhood,Lymphoblastic Leukemia, Acute, L1,Lymphoblastic Leukemia, Acute, L2,Lymphocytic Leukemia, L1,Lymphocytic Leukemia, L2,Acute Lymphoblastic Leukemia,Acute Lymphocytic Leukemia,Childhood ALL,L1 Lymphocytic Leukemia,L2 Lymphocytic Leukemia,Leukemia, Acute Lymphocytic,Leukemia, Acute Lymphoid,Leukemia, L1 Lymphocytic,Leukemia, L2 Lymphocytic,Lymphoid Leukemia, Acute,Precursor Cell Lymphoblastic Leukemia Lymphoma

Related Publications

R Surtees, and J Clelland, and S Heales
May 1999, Journal of inherited metabolic disease,
R Surtees, and J Clelland, and S Heales
January 1989, Archiv fur Geschwulstforschung,
R Surtees, and J Clelland, and S Heales
March 1988, Lancet (London, England),
R Surtees, and J Clelland, and S Heales
July 1996, Critical care medicine,
R Surtees, and J Clelland, and S Heales
September 1994, Journal of neurochemistry,
R Surtees, and J Clelland, and S Heales
January 1997, European journal of cancer (Oxford, England : 1990),
R Surtees, and J Clelland, and S Heales
December 2002, Best practice & research. Clinical haematology,
R Surtees, and J Clelland, and S Heales
March 1974, Journal of clinical pathology,
Copied contents to your clipboard!